Gene testing market is expected to see explosive growth in the coming years, with U.S. spending on gene tests set to rise sharply. According to a study conducted by UnitedHealthGroup’s Center of Health Reform and Modernization, U.S. spending on gene tests is expected to grow from $5 billion in 2010 to between $15 billion and $25 billion by 2021. Arrayit Corporation (OTC: ARYC), with its proprietary and patented microarray manufacturing platform and VIP “patent on chip” gene testing technology, has the technology to become a leader in gene testing market.
To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/
About Arrayit Corporation
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.
About Liston Street Pulse
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.
###
